Since it is reported that the distinct molecular subtypes of GBM may show a difference in prognosis and responses to treatments, we next examined the expression profile of RGS4 among the four subtypes (mesenchymal, classical, proneural and neural). The gene discussed is RGS4; the disease is glioblastoma.